Onc.AI receives US FDA’s breakthrough device designation for its serial CT response score deep learning model: San Carlos, California Saturday, February 8, 2025, 16:00 Hrs [IST] ...

While Europe has held a strong position in high-tech cancer innovation in the past, a report published on Monday by the European Patent Office (EPO) suggests that the bloc has lost its leading role to ...

Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...